Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

A Phase 1 Study of Flotetuzumab, a CD123 x CD3 DART ® Protein, Combined with MGA012, an Anti-PD-1 Antibody, in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Andrew H. Wei, PhD FRACP, FRCPA, MBBS, Chun Yew Fong, MBBS,PhDFRACP,FRCPA, Pau Montesinos, MD PhD, Maria Calbacho, MD, Jordi Sierra Gil, MD PhD, Jaime Perez De Oteyza, MD PhD, Jacob M. Rowe, MB, BS, Ofir Wolach, MD, Yishai Ofran, MD, Yakir Moshe, MD, Jichao Sun, PhD, Jan Baughman, MPH, Eileen McNulty, MS, Ezio Bonvini, MD, Jon M. Wigginton, MD, Jan K Davidson-Moncada, MD PhD

Blood (2019) 134 (Supplement_1): 2662.

https://doi.org/10.1182/blood-2019-125966

Published: 2019

Journal Articles

CAR T Cells Targeting FLT3 on AML Confer Potent Anti-Leukemic Activity and Act Synergistically with the FLT3 Inhibitor Midostaurin

Hardikkumar Jetani, BPharm, MS, Irene García-Cadenas, Thomas Nerreter, Julian Rydzek, Simone Thomas, Wolfgang Herr, Jordi Sierra, Halvard Bönig, Hermann Einsele, Michael Hudecek

Blood (2017) 130 (Supplement 1): 1351.

https://doi.org/10.1182/blood.V130.Suppl_1.1351.1351

Published: 2017

Journal Articles

High Correlation Clinical Responses to 1 st Line Acute Myeloid Leukemia Treatment with an Ex Vivo Native Environment Precision Medicine Test

Pau Montesinos, MD, Joan Ballesteros, David Martínez-Cuadrón, Joaquín Martínez-López, Josefina Serrano, Jaime Perez de Oteyza, Pascual Fernández, Gabriela Rodriguez-Macías, Mª Belén Vidriales, Pilar Herrera, MD PhD, Mar Tormo, MD PhD, Juan Bergua, Raimundo García, MD, Susana Vives, Mª Ángeles Fernández, Esperanza Lavilla, MD, Santiago Jimenez, Jose Antonio Pérez-Simón, Adriana Simiele, Ataulfo González, Bernardo J. González, Carmen Burgaleta, Juan Antonio López, Concepción Bethancourt, Guiomar Bautista, Arancha Alonso, Mercedes Colorado, Jordi Sierra, Begoña Navas, José Angel Hernández-Rivas, Juan Antonio Vera, Mª Lourdes Amador, Raúl Cordoba, MD, Adolfo de la Fuente, Fernando Ramos, MD PhD MPH, Carlos Javier Cerveró, Consolación Rayón, Olga Salamero, Edelmira Martí, Aurelio López, Teresa Olavé, Marta Gaspar, Julian Gorrochategui, José Luis Rojas, Cristina Gomez, Pilar Hernández, Alicia Robles, Ignacio Ortega, Jesús Villoria, Federico Moscardó, Iñaki Troconiz, Miguel A. Sanz, MD PhD

Blood (2015) 126 (23): 4837.

https://doi.org/10.1182/blood.V126.23.4837.4837

Published: 2015

Journal Articles

Matching of MHC Class I Chain-Related Genes a and B Is Associated with Reduced Incidence of Severe Acute Graft-Versus-Host Disease after Unrelated Hematopoietic Stem Cell Transplantation

Blood (2014) 124 (21): 664.

https://doi.org/10.1182/blood.V124.21.664.664

Published: 2014

Journal Articles

Allogeneic Hematopoietic Stem-Cell Transplantation (HSCT) in First Complete Remission Is Superior Compared to Chemotherapy/Autologous HSCT in Patients with Intermediate-Risk Cytogenetics Acute Myeloid Leukemia Lacking Mutations in NPM1 , FLT3 -ITD, and CEBPA : A Joint Study of AMLSG, Cetlam and Acute Leukemia Working Party of EBMT

Blood (2014) 124 (21): 324.

https://doi.org/10.1182/blood.V124.21.324.324

Published: 2014

Journal Articles

Pharmacological Profile Of Cytarabine and Idarubicin In Patient Samples (ex vivo) With Newly Diagnosed Acute Myeloid Leukemia Identifies Responders Vs Non Responders

Blood (2013) 122 (21): 3923.

https://doi.org/10.1182/blood.V122.21.3923.3923

Published: 2013

Journal Articles

Population Pharmacological Profiles Of AML Treatments In Patient Samples By Automated Flow Cytometry; A Bridge To Individualized Medicine

Blood (2013) 122 (21): 1347.

https://doi.org/10.1182/blood.V122.21.1347.1347

Published: 2013

Journal Articles

Personalizing Therapies With Ex Vivo Pharmacological Responses May Uncover The Differences Between IDA-DNR-MIT Among European AML Protocols

Blood (2013) 122 (21): 1294.

https://doi.org/10.1182/blood.V122.21.1294.1294

Published: 2013

Journal Articles

Identification Of Patients At High Risk Of Chronic Graft-Versus-Host Disease: Gvhd Prophylaxis

Gabriel Afram, MD, Jose Antonio Pérez Simón, MD, PhD, Mats Remberger, PhD, Teresa Caballero-Velázquez, MD, PhD, Rodrigo Martino, MD, PhD, Jose Luis Piñana, MD, Olle Ringden, MD, Albert Esquirol, MD, Dolores Caballero, MD, PhD, Irene Garcia, MD, Lucía López-Corral, MD, PhD, Jordi Sierra, Oriana López-Godino, Per T. Ljungman, MD, PhD, Jesus F San Miguel, MD, PhD, Hans Hagglund, MD PhD

Blood (2013) 122 (21): 4611.

https://doi.org/10.1182/blood.V122.21.4611.4611

Published: 2013

Journal Articles

Outcome of Second Allogeneic SCT Following Relapse of Hematological Malignancies After a First Allogeneic SCT

Blood (2011) 118 (21): 3056.

https://doi.org/10.1182/blood.V118.21.3056.3056

Published: 2011

Journal Articles

The Combination of Siromilus Plus Tacrolimus (SiTac) Improves the Results of Cyclosporine Plus Mycophenolate Mofetil (CsAMMF) After Reduced Intensity Conditioning (RIC) Unrelated Donor Allogeneic Transplantation

Jose Antonio Perez-Simón, Sr., MD, PhD, Rodrigo Martino, MD, PhD, Rocio Parody, MD, M. Cabrero, Lucía López-Corral, David Valcarcel, MD, Carmen Martinez, MD, Carlos Solano, Rafael De La Camara, MD, Inmaculada Heras, Dolores Caballero, MD, Jordi Sierra, MD, PhD

Blood (2011) 118 (21): 890.

https://doi.org/10.1182/blood.V118.21.890.890

Published: 2011

Journal Articles

Improved Response to 5-Azacitidine in Patients with Primary Compared to Secondary AML, Particularly If NPM1 Mutations Are Present,

Ana Garrido, Miguel Ortin, Montserrat Hoyos, Rodrigo Martino, MD, PhD, Anna Aventin, MD, Josep Nomdedeu, MD, Salut Brunet, Jordi Sierra

Blood (2011) 118 (21): 3562.

https://doi.org/10.1182/blood.V118.21.3562.3562

Published: 2011

Journal Articles

5-Azacytidine Before or After Stem Cell Transplantation in Acute Myeloid Leukaemia (AML) and Myelodysplastic Syndromes (MDS)

Ana Garrido, Miguel Ortín, Rodrigo Martino, MD, PhD, Josep Nomdedeu, MD, Ana Aventin, Montserrat Hoyos, Salut Brunet, Jordi Sierra

Blood (2011) 118 (21): 4267.

https://doi.org/10.1182/blood.V118.21.4267.4267

Published: 2011

Journal Articles

Profile of Chronic Transfusion-Dependent Patients In Spain (20CH Study)

Blood (2010) 116 (21): 4408.

https://doi.org/10.1182/blood.V116.21.4408.4408

Published: 2010

Journal Articles

Prognostic Value of Monosomal Karyotype in Patients with Primary Acute Myeloid Leukemia On Behalf of Spanish CETLAM Group.

Blood (2009) 114 (22): 1003.

https://doi.org/10.1182/blood.V114.22.1003.1003

Published: 2009

Journal Articles

Treatment of Chronic Myeloid Leukemia with Imatinib. A Single Centre Experience

Anna Parente, Anna Sureda, Anna Aventin, Salut Brunet, Rodrigo Martino, Javier Briones, David Valcarcel, Julio Delgado, Josep Nomdedeu, Jordi Sierra

Blood (2008) 112 (11): 4289.

https://doi.org/10.1182/blood.V112.11.4289.4289

Published: 2008

Journal Articles

Targeting the Poor Mobilizing Population of Patients for An Autologous Transplantation Procedure: A Single Centre Experience

Ana Marco, Anna Sureda, Pedro Madoz, Gregorio Martin-Henao, Salut Brunet, Rodrigo Martino, Javier Briones, David Valcarcel, Julio Delgado, Jordi Sierra

Blood (2008) 112 (11): 4136.

https://doi.org/10.1182/blood.V112.11.4136.4136

Published: 2008

Journal Articles

Unrelated Transplants for Poor Prognosis Adult Acute Lymphoblastic Leukemia: Long-Term Comparative Analysis Based on the Hematopoietic Progenitor Source.

Blood (2008) 112 (11): 969.

https://doi.org/10.1182/blood.V112.11.969.969

Published: 2008

Journal Articles

Long Remission Are Possible after Non Myeloablative Transplant in Patients with Follicular Non-Hodgkin’s Lymphoma (NHL): Results of Two Prospectives Multicenter Trials.

María-Dolores Caballero, MD, PhD, Rodrigo Martino, MD, María-Victoria Mateos, MD, Phd, Javier Briones, MD, Javier de la Serna, MD, Jose-Francisco Tomás, MD, Reyes Arranz, MD, Jose-Luis Díez, MD, Vicente Rubio, MD, Josep-María Ribera, MD, José-María Moraleda, MD, PhD, Guillermo Sanz, MD, Alvaro Urbano, MD, PhD, José Sarrá, MD, Antonia Sampol, MD, Jordi Sierra, MD, PhD, J. F. San Miguel, MD, PhD

Blood (2006) 108 (11): 3024.

https://doi.org/10.1182/blood.V108.11.3024.3024

Published: 2006

Journal Articles

Steady remission of scleromyxedema 3 years after autologous stem cell transplantation: an in vivo and in vitro study

Isabel Illa, Carolina de la Torre, Ricardo Rojas-Garcia, Antoni Altes, Rafael Blesa, Jordi Sierra, Eduard Gallardo

Blood (2006) 108 (2): 773–774.

https://doi.org/10.1182/blood-2006-01-0186

Published: 2006

NARROW

A Phase 1 Study of Flotetuzumab, a CD123 x CD3 DART ® Protein, Combined with MGA012, an Anti-PD-1 Antibody, in Patients with Relapsed or Refractory Acute Myeloid Leukemia

CAR T Cells Targeting FLT3 on AML Confer Potent Anti-Leukemic Activity and Act Synergistically with the FLT3 Inhibitor Midostaurin

High Correlation Clinical Responses to 1 st Line Acute Myeloid Leukemia Treatment with an Ex Vivo Native Environment Precision Medicine Test

Matching of MHC Class I Chain-Related Genes a and B Is Associated with Reduced Incidence of Severe Acute Graft-Versus-Host Disease after Unrelated Hematopoietic Stem Cell Transplantation

Pharmacological Profile Of Cytarabine and Idarubicin In Patient Samples (ex vivo) With Newly Diagnosed Acute Myeloid Leukemia Identifies Responders Vs Non Responders

Population Pharmacological Profiles Of AML Treatments In Patient Samples By Automated Flow Cytometry; A Bridge To Individualized Medicine

Personalizing Therapies With Ex Vivo Pharmacological Responses May Uncover The Differences Between IDA-DNR-MIT Among European AML Protocols

Identification Of Patients At High Risk Of Chronic Graft-Versus-Host Disease: Gvhd Prophylaxis

Outcome of Second Allogeneic SCT Following Relapse of Hematological Malignancies After a First Allogeneic SCT

The Combination of Siromilus Plus Tacrolimus (SiTac) Improves the Results of Cyclosporine Plus Mycophenolate Mofetil (CsAMMF) After Reduced Intensity Conditioning (RIC) Unrelated Donor Allogeneic Transplantation

Improved Response to 5-Azacitidine in Patients with Primary Compared to Secondary AML, Particularly If NPM1 Mutations Are Present,

5-Azacytidine Before or After Stem Cell Transplantation in Acute Myeloid Leukaemia (AML) and Myelodysplastic Syndromes (MDS)

Profile of Chronic Transfusion-Dependent Patients In Spain (20CH Study)

Prognostic Value of Monosomal Karyotype in Patients with Primary Acute Myeloid Leukemia On Behalf of Spanish CETLAM Group.

Treatment of Chronic Myeloid Leukemia with Imatinib. A Single Centre Experience

Targeting the Poor Mobilizing Population of Patients for An Autologous Transplantation Procedure: A Single Centre Experience

Unrelated Transplants for Poor Prognosis Adult Acute Lymphoblastic Leukemia: Long-Term Comparative Analysis Based on the Hematopoietic Progenitor Source.

Long Remission Are Possible after Non Myeloablative Transplant in Patients with Follicular Non-Hodgkin’s Lymphoma (NHL): Results of Two Prospectives Multicenter Trials.

Steady remission of scleromyxedema 3 years after autologous stem cell transplantation: an in vivo and in vitro study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only